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Synopsis: Three-dimensional power Doppler ultrasonography showed that placental 
vascularization is reduced in pregnancies complicated by intrauterine growth 
restriction. 
ABSTRACT 
Objective: To examine placental vascularization using three-dimensional power 
Doppler (3DPD) ultrasonography in pregnancies complicated by intrauterine growth 
restriction (IUGR). 
Methods: The present prospective study was conducted at the University of Szeged 
(Szeged, Hungary) from February 2012 to March 2013. Women with a singleton 
pregnancy who attended the maternity outpatient ward in the second or third 
trimester were enrolled consecutively. Women were divided into two groups: those 
with a normal pregnancy and those with a pregnancy complicated by IUGR. Three 
3DPD indices—vascularization index (VI), flow index (FI), vascularization flow index 
(VFI)—were assessed. 
Results: A total of 223 women were enrolled: 171 were in the control group and 52 in 
the IUGR group. Median VI was 3.7% (interquartile range [IQR] 3.2%–4.2%) in the 
IUGR group and 10.1% (IQR 8.6%–10.9%) in the control group (P=0.001). Median FI 
was 40.0 (IQR 39.7–42.5) in the IUGR group and 45.1 (IQR 44.1–53.1) in the control 
group (P=0.012). Median VFI was 2.2 (IQR 2.1–2.4) in the IUGR group and 4.8 (IQR 
4.4–5.3) in the control group (P<0.001). 
Conclusion: Placental vascularization was reduced in pregnancies complicated by 
IUGR. 
1. Introduction 
Modification of the fetoplacental circulation throughout pregnancy leads to alterations 
in the placental vascularization and the development of the fetoplacental unit. 
Intrauterine growth restriction (IUGR)—diagnosed when the fetus has an estimated 
weight below the 10th percentile for its gestational age [1,2]—is one of the most 
serious complications. Usually, it is a symptom of damaged placental function, but 
IUGR can be caused by maternal disease (e.g. diabetes). 
 
Intrauterine growth restriction (IUGR) results in clinically relevant perinatal 
complications [3]. The clinical manifestations of IUGR depend primarily on the 
duration of contributing factors, and how long the fetus was affected [3]. 
 
The present study was performed to test the hypothesis that placental 
vascularization, which is decreased in pregnancies complicated by IUGR, is related 
not only to the frequency of cesarean delivery, but also to risk factors and clinical 
outcome. The aim of the present study was to evaluate the three-dimensional (3D) 
Doppler parameters of the placenta; assess the influence of gravidity, parity, and 
body mass index on these parameters; and evaluate the correlation between these 
parameters and perinatal outcomes in women with a pregnancy complicated by 
IUGR. 
 
2. Materials and methods 
A prospective study was conducted in the maternity outpatient ward of the 
Department of Obstetrics and Gynecology at the University of Szeged, Szeged, 
Hungary, between February 1, 2012, and March 31, 2013. Women with a singleton 
pregnancy who attended the maternity outpatient ward in the second or third 
trimester were enrolled consecutively. Several exclusion criteria were used: multiple 
pregnancy; thickened (>3 mm) nuchal translucency between the start of the 11th and 
the end of the 13th week of pregnancy; structural or chromosomal abnormality during 
the fetal or neonatal period; placenta previa; self-declared intake of illicit drugs, 
alcohol, caffeine, or nicotine; pharmaceutical treatment for disorders of the circulatory 
system (e.g. treatment with oxerutins or calcium dobesilate monohydrate);systemic 
disease (e.g. autoimmune disease, vasculitis, hemophilia, thrombophilia, diabetes, or 
HIV infection);and pregnancy-related disease [4]. All participants provided written 
informed consent. The research protocol was approved by the university’s Ethics 
Committee before the study started, and the study was carried out in accordance with 
the Declaration of Helsinki. 
 
The women were divided into two groups: women with a normal pregnancy (control 
group) and women with a pregnancy complicated by IUGR (IUGR group) [2]. The 
diagnosis and enrollment of women affected by IUGR was based on estimated fetal 
weight after two-dimensional ultrasound biometry during routine screening. The 3D 
power Doppler (3DPD) indices were determined to evaluate the perfusion of the 
placenta (uteroplacental and fetoplacental blood flow [5,6]): vascularization index 
(VI), flow index (FI), and vascularization flow index (VFI) throughout pregnancy. The 
VI corresponds to the ratio of the number of color voxels to the total number of 
voxels; it reflects the number of blood vessels within the volume of interest 
(vascularity). The FI is the ratio of the number of intensity-weighted color voxels to 
the total number of color voxels and represents the average blood flow intensity 
(blood flow). The VFI is the ratio of the number of intensity-weighted color voxels to 
the total number of voxels; it integrates data on vessel presence (vascularity) and 
number of blood cells transferred (blood flow). The values for all three indices range 
from 0 to 100 [6]. 
 
Two-dimensional, 3D, and color Doppler examinations were performed on the same 
day using a Voluson 730 (GE Healthcare, Zipf, Austria) ultrasound machine with an 
RAB2–5 (2–5 MHz) convex probe. We used the placental vascular sonobiopsy 
method as described by Mercé et al. (Figure 1) [6]. The ultrasound volumes collected 
were assessed by a specialist in 3D analysis (A.S.) using the Virtual Organ 
Computer-aided AnaLysis (VOCAL) program within 4D View version 10.4 (GE 
Healthcare, Zipf, Austria). 
 
Perinatal outcomes (umbilical cord arterial pH; 1-minute, 5-minute, and 10-minute 
Apgar scores; birth weight; and birth length) were compared between women with 
and without different risk factors (decreased placental vascularization indices [VI, FI, 
and VFI], maternal age, pregestational body mass index, excessive weight gain, and 
mode of delivery). Demographic data were collected from medical records. 
 
The statistical analysis was conducted with SPSS for Windows version 17.0 (SPSS 
Inc, Chicago, IL, USA). An analysis of variance (ANOVA) was carried out to examine 
the association of the 3DPD indices with the gravidity, parity, and pregestational body 
mass index (BMI). The Mann–Whitney U test, the t test, and the z-score were used to 
compare 3DPD indices (VI, FI, VFI); estimated fetal weight, birth weight, and birth 
length; the mode of delivery; the occurrence of intrauterine complications; the 
necessity of transfer to the neonatal intensive care unit; the Apgar scores at 1, 5, and 
10 minutes; and the umbilical cord arterial pH between the IUGR group and the 
control group. P≤0.01 was considered statistically significant. A quantile regression 
method was used to investigate the relationship between 3DPD indices (VI, FI, VFI) 
and gravidity, parity, and BMI. 
 
3. Results 
A total of 223 women were enrolled: 171 were in the control group and 52 were in the 
IUGR group. Demographic and obstetric characteristics are shown in Table 1. 
Placental location and 1-minute Apgar score did not differ significantly between 
groups. Gravidity, parity, prepregnancy BMI, umbilical cord artery pH, and 5-minute 
and 10-minute Apgar scores did differ significantly (Table 1). 
 
Women in the IUGR group had significantly lower 3DPD indices (VI, FI, and VFI) 
values than did the control group (Figure 2). All 3DPD indices remained constant 
throughout pregnancy in the normal pregnancies.  We did not manage to perform 
curve analysis for the rate of reduction of 3DPD indices plotted against gestational 
age in the IUGR group, no trend line could be fitted to the values, and there was no 
linear, exponential, logarithmic etc. regression found in these cases. Therefore we 
would like to eliminate this sentence from the section ‘Results’  You say that 3DPD 
indices remained constant throughout pregnancy in the control group (i.e. 
there was no change over time), but you do not mention whether there was 
change over time in the IUGR group. Please add some text to explain whether 
indices remained constant in the IUGR group.] 3DPD indices were significantly 
lower in different amount in IUGR group compared to normal group. [Author: Please 
clarify what you mean in this sentence; it does not make sense as it stands. If 
you are just trying to say that 3DPD indices were lower in the IUGR group, you 
said that in the first sentence of this paragraph, so can this sentence be 
deleted? Yes, this sentence can be deleted ]  
 
Table 2 shows the comparison of vascularization indices among women with different 
gravidities, parities, and pregestational BMIs. Gravidity, parity, and prepregnancy BMI 
had no significant effect on VI, FI, VFI by quantile regression analyses (P>0.01), but 
there were significant differences in VI, FI, VFI between the control and IUGR groups 
(P<0.01). 
 
Perinatal complications occurred among 12 (23.1%) neonates in the IUGR group and 
12 (7.0%) in the control group (P=0.01). Neonatal intensive care was needed for 16 
(30.8%) infants in the IUGR group and 13 (7.6%) in the control group (P=0.01). 
 
Median length of pregnancy was 38.4 weeks (interquartile range 37.3–39.1) in the 
study group and 39.1 weeks (interquartile range 38.1–40.0; P=0.01). The mean birth 
weight was 2674.4 ± 752.1 g in the study group and 3351.9 ± 522.4 g in the control 
group (P=0.01). The mean birth length was 46.5 ± 3.4 cm in the study group and 
49.6 ± 2.45 cm in the control group (P=0.0051). 
 
The mean z-score for the estimated fetal weight in IUGR pregnancies measured from 
30 to 38 weeks of pregnancy was –2.9, indicating that the estimated fetal weights in 
the IUGR group were below the average measured in the control group by nearly 
three times the standard deviation. 
 
4. Discussion 
The present prospective study focused on the determination of placental 
vascularization indices (VI, FI, and VFI) using Mercé-type sonobiopsy [6] and 
demonstrated that placental vascularization was reduced in pregnancies complicated 
by IUGR compared with normal pregnancies, confirming previous results [7–9]. 
However, in contrast to the previous studies [7–9], in which the authors only 
compared the placental vascularization in normal and IUGR pregnancies, the present 
study also investigated the relationship between the 3DPD indices and perinatal 
outcomes. The depression of 3DPD indices correlates with the elevation rate of 
perinatal outcomes. 
 
Various methods for measurement of placental vascular flow in vivo have been 
reported. de Paula et al. [10] scanned the whole placenta with the VOCAL technique 
but this method could not be utilized in almost all patients at late stages of pregnancy 
when the high-risk problems (i.e. IUGR) develop. Guiot et al. [7] determined 3DPD 
indices at five different placental locations. Noguchi et al. [8] investigated the 
vascularization of the entire placenta by calculating average values from 9–12 
spherical samples (Noguchi type placental sonobiopsy). However, neither the 
sampling volume nor the number of spherical samples obtained was standardized. In 
fact, samples from barely vascularized edges of the placenta and from better 
vascularized central parts were included in the calculation of average values, which 
might have had a considerable influence on the results obtained. 
 
Mercé type sonobiopsy was used in the present study, because this method has 
been well defined and validated, and is characterized by low intraobserver and 
interobserver error [6,11]. Mercé et al. [6] examined a placental volume of 
3×3×3 mm3 located at the site of insertion of umbilical cord, which is the most 
vascularized portion of the placenta. This method can be used not only in the first 
trimester, when the overwhelming majority of high-risk pregnancies has not been 
developed yet, but also during the second and third trimester. 
 
There is a debate over the normal range for each of the placental vascularization 
indices because the results from different authors are conflicting. The present 
findings are consistent with the results from Guiot et al. [7] and de Paula et al. [10] 
who found that the placental indices remained constant throughout pregnancy. 
Possible explanations for the discrepancy between the results from different authors 
include the use of different measurement techniques, low case numbers, and lacking 
information on measured volumes and ultrasound equipment settings. 
 
In the present study, the women with an IUGR pregnancy and those in the control 
group did not differ significantly in terms of maternal age, gravidity, parity, 
pregestational BMI, or pregnancy duration at the time of the examination. This finding 
indicates that these factors had no influence on the condition of the arteries or the 
extent of angiogenesis during pregnancy. 
 
The frequency of cesarean delivery was significantly higher among women with an 
IUGR pregnancy than in the control group. Growth-restricted fetuses respond 
sensitively to stress during labor and often do not tolerate vaginal delivery; thus 
cesarean delivery is performed more frequently.  
 
The 5-minute and 10-minute Apgar scores showed significant differences with regard 
to VI, FI, and VFI, which can be explained by poor postnatal adaptation of infants 
who had been growth-restricted in the uterus. Apgar scores decreased with 
decreasing values for all 3DPD indices. Complications such as hypothermia, 
hypoglycemia, polycythemia, hyperviscosity, and breathing problems emerged, and 
neonatal intensive care was necessary more often in IUGR cases [3]. The decrease 
in all three 3DPD indices was significant. The VFI was the most sensitive predictor of 
complications. However, we recommend use of the FI to screen for IUGR 
pregnancies at increased risk of perinatal complications because this parameter is 
minimally influenced by other factors, such as equipment settings. The FI has the 
lowest coefficient of variation and the lowest rate of intraobserver/interobserver errors 
of the three vascularization indices [7]. 
 
The present study confirms previous results [5] indicating that the placental location 
has no significant influence on the three placental vascularization indices. In the 
previous study, Guimarães Filho et al. [5] examined 283 women between 26–35 
weeks of pregnancy and monitored the effect of the position of the placenta on 
changes in the three indices. In the present study, women with placental adhesion 
anomalies and morphological disorders were excluded because such pregnancies 
can be affected by insufficient circulation from the beginning of the pregnancy [12] 
and this could have influenced the findings. 
 
In the present study, we aimed at using an appropriately validated and reproducible 
method for assessing placental vascularization that can be adopted in maternal care 
on a routine basis. Previously published ultrasonography methods cannot be applied 
to general maternal care without reservations, partly because the sampling volume 
[7] or the placental location and the number of samples obtained [8] were not 
standardized. Moreover, some methods used by other authors involve visualization of 
the entire placenta [7–9], which is not possible in the third trimester. 
 
In theory, the ultrasound equipment settings could have a significant influence on the 
values of the 3DPD indices, making it difficult to compare the findings from different 
studies. However, no such effect has been observed in case–control studies [7–9]. 
Therefore, standard machine settings were used in the present study. Volume 
acquisition lasted 5–15 seconds during a time when there was no fetal motion; the 
mother also remained as motionless as possible to avoid the display of artifacts. 
 
In conclusion, the differences in placental vascular flow indices between normal and 
IUGR pregnancies can be detected easily and the findings do not depend on 
equipment settings. The present results also confirm a strong correlation between the 
extent of reduced placental vascularization and perinatal outcome in pregnancies 
complicated by IUGR. We recommend the use of Mercé-type placental sonobiopsy 
[6] for the monitoring of IUGR pregnancies so as to reduce the rate and range of 
perinatal complications. With the development of telemedicine, the volumetric scans 
from women with a pregnancy complicated by IUGR could be forwarded to experts, 
making the follow-up of high-risk pregnancies more objective. However, it is 
important to emphasize that a therapeutic conclusion can only be drawn on the basis 
of the complete clinical background. 
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Figure legends 
Figure 1 Mercé-type placental vascular sonobiopsy [6] and placental three-
dimensional power Doppler indices. The yellow circle corresponds to the Mercé-type 
placental vascular sonobiopsy (a 28-mL volume that forms a part of the placenta 
directly at the adhesion of umbilical cord). 
 
Figure 2 Three-dimensional power Doppler indices in the IUGR group (n=52) and the 
control group (n=171). Abbreviations: VI, vascularization index; IUGR, intrauterine 
growth restriction; FI, flow index; VFI, vascularization flow index. The boxes represent 
the interquartile range, with the median shown as a dotted arrow; the most extreme 
values are also shown. 
Table 1 Demographic and obstetric characteristics.a 
 Control group 
(n=171) 
IUGR group 
(n=52) 
P 
value 
Age, y 31.0 (28–34) 30.0 (26–34) 0.1 
Pregnancy duration at the time of 
ultrasonography, wk 
30.4 (19.0–37.0) 31.9 (24.1–37.6) 0.1 
Median length of pregnancy, wk 39.1 (38.1–40.0) 38.4 (37.3–39.1) 0.2 
Gravidity    
<3 123 (71.9) 28 (53.8) 0.01 
≥3 48 (28.1) 24 (46.1) 0.01 
Parity b    
<3 110 (73.3) 21 (55.3) 0.01 
≥3 40 (26.7) 17 (44.7) 0.01 
Prepregnancy BMI 22.1 ± 2.5 21.9 ± 1.5 0.02 
Perinatal complications  12 (7.0) 12 (23.1) 0.01 
Neonatal care 13 (7.6) 16 (30.8) 0.01 
Cesarean delivery 45 (26.3) 31 (59.6) 0.01 
Apgar score    
1 min 8.9 ± 2.3 9.0 ± 1.4 0.12 
5 min 9.3 ± 1.3 9.7 ± 0.9 0.01 
10 min 9.5 ± 0.8 9.8 ± 1.0 0.01 
Birth length, cm 49.6 ± 2.45 46.5 ± 3.4 0.01 
Birth weight, g 3351.9 ± 522.4 2674.4 ± 752.1 0.01 
Umbilical cord arterial pH 7.2 ± 0.2 6.9 ± 1.6 0.01 
Placental location    
Anterior wall 97 (56.7) 29 (55.8) 0.23 
Posterior wall 74 (43.3) 23 (44.2) 0.22 
a Values are given as median (interquartile range), number (percentage), or mean ± SD. 
b Data available for 150 participants in the control group and 38 in the IUGR group. 
 
Table 2 Comparison of vascularization indices among women with different gravidity, parity, and prepregnancy BMI in the control group and IUGR group. 
 Mean vascularization index, % Mean flow index Mean vascularization flow index 
 Control 
group 
IUGR group Control 
group 
IUGR group Control 
group 
IUGR group 
Gravidity a a b b a a 
1 c 9.4 3.5 44.0 39.7 4.4 2.1 
2 d 10.9 3.5 45.5 39.7 5.3 2.4 
3 e 10.5 3.8 47.1 39.8 5.0 2.2 
4 f 10.0 3.3 42.5 42.5 4.6 2.3 
5 g 8.6 – 53.1 – 5.1 – 
Parity h h i i j j 
1 d 9.4 5.3 44.2 39.5 4.4 2.0 
2 e 11.3 4.8 46.0 42.5 5.5 2.0 
3 f 11.1 6.4 47.1 39.0 5.5 2.7 
4 4.6 – 43.0 – 2.0 – 
Prepregnancy BMI k k l l j j 
Normal 5.4 4.8 44.7 39.9 5.1 2.2 
Obese 4.0 3.4 42.3 38.6 3.5 1.6 
Normal but excessive weight gain 
during pregnancy m 
5.3 4.4 46.3 39.8 4.5 2.1 
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by the square of height in meters); IUGR, intrauterine growth restriction. 
a Within-group comparison P=0.1. 
b Within-group comparison P=0.3. 
c Control group n=67; IUGR group n=18. 
d Control group n=56; IUGR group n=10. 
e Control group n=31; IUGR group n=16. 
f Control group n=14; IUGR group n=8. 
g Control group n=3; IUGR group n=0. 
h Within-group comparison P=0.012. 
i Within-group comparison P=0.068. 
j Within-group comparison P=0.08. 
k Within-group comparison P=0.02. 
l Within-group comparison P=0.28. 
m According to guidelines from the Mayo clinic [13]. 
